Humana Inc (HUM) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.067x

Based on the latest financial reports, Humana Inc (HUM) has a cash flow conversion efficiency ratio of 0.067x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.25 Billion) by net assets ($18.65 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Humana Inc (HUM) balance sheet quality index to measure how much of total assets are equity-financed.

Humana Inc - Cash Flow Conversion Efficiency Trend (1990–2025)

This chart illustrates how Humana Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Humana Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Humana Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Humana Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Ingersoll Rand Inc
NYSE:IR
0.035x
Oil & Natural Gas Corporation Limited
NSE:ONGC
0.148x
M&T Bank Corporation
NYSE:MTB
0.036x
Ping An Bank Co Ltd
SHE:000001
0.198x
ANSYS Inc
NASDAQ:ANSS
0.065x
Fiserv, Inc.
NYSE:FI
0.072x
Arch Capital Group Ltd.
NASDAQ:ACGL
0.049x
Transurban Group
AU:TCL
0.108x

Annual Cash Flow Conversion Efficiency for Humana Inc (1990–2025)

The table below shows the annual cash flow conversion efficiency of Humana Inc from 1990 to 2025. For the full company profile with market capitalisation and key ratios, see Humana Inc stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $17.74 Billion $921.00 Million 0.052x -71.21%
2024-12-31 $16.45 Billion $2.97 Billion 0.180x -26.07%
2023-12-31 $16.32 Billion $3.98 Billion 0.244x -18.25%
2022-12-31 $15.37 Billion $4.59 Billion 0.298x +112.46%
2021-12-31 $16.10 Billion $2.26 Billion 0.140x -65.80%
2020-12-31 $13.73 Billion $5.64 Billion 0.411x -6.43%
2019-12-31 $12.04 Billion $5.28 Billion 0.439x +105.27%
2018-12-31 $10.16 Billion $2.17 Billion 0.214x -48.04%
2017-12-31 $9.84 Billion $4.05 Billion 0.412x +127.17%
2016-12-31 $10.69 Billion $1.94 Billion 0.181x +115.97%
2015-12-31 $10.35 Billion $868.00 Million 0.084x -49.98%
2014-12-31 $9.65 Billion $1.62 Billion 0.168x -8.94%
2013-12-31 $9.32 Billion $1.72 Billion 0.184x -15.26%
2012-12-31 $8.85 Billion $1.92 Billion 0.217x -15.70%
2011-12-31 $8.06 Billion $2.08 Billion 0.258x -20.36%
2010-12-31 $6.92 Billion $2.24 Billion 0.324x +31.55%
2009-12-31 $5.78 Billion $1.42 Billion 0.246x +11.68%
2008-12-31 $4.46 Billion $982.31 Million 0.220x -27.47%
2007-12-31 $4.03 Billion $1.22 Billion 0.304x -44.98%
2006-12-31 $3.05 Billion $1.69 Billion 0.552x +118.42%
2005-12-31 $2.47 Billion $625.63 Million 0.253x +51.96%
2004-12-31 $2.09 Billion $347.81 Million 0.166x -26.05%
2003-12-31 $1.84 Billion $413.14 Million 0.225x +12.47%
2002-12-31 $1.61 Billion $321.41 Million 0.200x +102.54%
2001-12-31 $1.51 Billion $148.96 Million 0.099x +235.86%
2000-12-31 $1.36 Billion $40.00 Million 0.029x -83.51%
1999-12-31 $1.22 Billion $217.00 Million 0.178x +296.22%
1998-12-31 $1.69 Billion $76.00 Million 0.045x -79.45%
1997-12-31 $1.32 Billion $289.00 Million 0.219x -16.98%
1996-12-31 $1.29 Billion $341.00 Million 0.264x +126.45%
1995-12-31 $1.29 Billion $150.00 Million 0.117x -58.62%
1994-12-31 $1.06 Billion $298.00 Million 0.282x +35.35%
1993-12-31 $889.00 Million $185.00 Million 0.208x -37.76%
1992-12-31 $2.02 Billion $674.00 Million 0.334x +11.20%
1991-12-31 $2.01 Billion $604.00 Million 0.301x -30.63%
1990-12-31 $1.75 Billion $758.30 Million 0.433x --

About Humana Inc

NYSE:HUM USA Healthcare Plans
Market Cap
$43.69 Billion
Market Cap Rank
#821 Global
#367 in USA
Share Price
$363.86
Change (1 day)
-0.76%
52-Week Range
$163.67 - $409.42
All Time High
$553.59
About

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medic… Read more